ReviewFrontiers in artificial intelligence2026
A comprehensive study on cervical cancer diagnosis using deep learning and artificial intelligence techniques.
Review in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer is a significant health problem across the globe, especially in nations with low or middle incomes, where access to early screening is limited and contributes to high mortality rates. Traditional diagnostic methods, including Papanicolaou smears (Pap smears) and Human Papillomavirus testing (HPV testing), often suffer from accessibility constraints, lower accuracy, and scalability issues. Recent advancements in artificial intelligence (AI) and Machine Learning (ML) have exhibited significant efficacy by improving detection accuracy and streamlining the diagnostic procedure. This review discusses AI-driven methodologies, including deep learning models (EfficientNetB0, Cervical Net), hybrid frameworks, and ensemble techniques. This study examines important obstacles related to class imbalance, data privacy, and model interpretability while also presenting a solution known as the Adaptive Synthetic Minority Over-Sampling Technique combined with Tomek Links (Adaptive SMOTE Tomek) for data augmentation and federated learning (FL) for secure, distributed AI model training. The outcomes emphasize AI's vital role in improving cervical cancer screening and correspond with the World Health Organization's (WHO) 2030 goals for cervical cancer eradication. Future research should focus on real-world validation, improved generalization, and the integration of AI in clinical settings to ensure widespread usage and reliability. This work is useful for medical professionals in cervical cancer diagnosis, in addition to traditional screening methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.